The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
came out of a group at yale and a guy called robert berman — who did an early study in 2000 — giving ketamine a single catamaran infusion to patients with treatment resistant depression and they showed the thing which was kind of groundbreaking and that's was that you could get this rapid reduction in — depressive symptoms
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.